Kleiner-Hancock et al. BMC Cancer 2010, 10:394 http://www.biomedcentral.com/1471-2407/10/394 1R21CA116324 (JLC). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. Ms. Remeika was supported by the Summer Undergraduate Pharmacology Experience in Research (SUPER) program, which received funding from the American Society for Pharmacology and Experimental Therapeutics (ASPET) Summer Undergraduate Research Fellowship (SURF), the LSU Health Sciences Foundation, and the Department of Pharmacology, Toxicology, and Neuroscience. Author details 1Department of Pharmacology, Toxicology & Neuroscience, Louisiana State University Health Sciences Center-Shreveport, 1501 Kings Hwy, Shreveport, Louisiana, 71103 USA. 2Department of Medicine, Louisiana State University Health Sciences Center-Shreveport, 1501 Kings Hwy, Shreveport, Louisiana, 71103 USA. 3Department of Biochemistry and Molecular Biology, Louisiana State University Health Sciences Center-Shreveport, 1501 Kings Hwy, Shreveport, Louisiana, 71103 USA. 4Department of Pathology, Louisiana State University Health Sciences Center-Shreveport, 1501 Kings Hwy, Shreveport, Louisiana, 71103 USA. 5Department of Cellular Biology & Anatomy, Louisiana State University Health Sciences Center-Shreveport, 1501 Kings Hwy, Shreveport, Louisiana, 71103 USA. 6Center for Experimental Cancer Therapeutics, Cancer Prevention & Control Group, Feist-Weiller Cancer Center, 1501 Kings Hwy, Shreveport, LA, 71103 USA. Authors’ contributions The research team was directed equally by HK and JC. HK and MJM carried out the NF- B-RE-luc mouse study. JC, ZS, DR, AR, JR, and HK conducted the tumor studies in the SCID mice. HK and MP conducted the CDNB, DCNB, and NQO assays. RS conducted the statistical analyses. PA analyzed the tissues for histopathology. The manuscript was written by HK with the assistance of AR, DR, MJM, RS, and JC. All the authors have seen the manuscript and agree to its contents. Authors’ information HK and JC are Associate professors (Ph.D.); RS is an Associate professor of Medicine (Ph.D.); MJM is a Professor (Ph.D.); PA is a Professor of Pathology (M.D.). ZS and DR were Ph.D. students during the study, and AR was a summer undergraduate intern. MP and JR are Research Associates/Lab Managers (B.S.). Competing interests The authors declare that they have no competing interests. Received: 13 March 2010 Accepted: 26 July 2010 Published: 26 July 2010 References 1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ: Cancer Statistics, 2009. CA Cancer J Clin 2009, 59(4):225-49. 2. Alam M, Ratner D: Cutaneous squamous-cell carcinoma. N Engl J Med 2001, 344(13):975-983. 3. Karin M: Nuclear factor-kappaB in cancer development and progression. Nature 2006, 441(7092):431-436. 4. Aggarwal BB: Nuclear factor-kappaB: the enemy within. Cancer Cell 2004, 6(3):203-208. 5. Kondo A, Ohigashi H, Murakami A: A potent inhibitor of tumor promoter- induced Epstein-Barr virus activation, 1’-acetoxychavicol acetate from Languas galanga, a traditional Thai condiment. Bioscience Biotechnology Biochemistry 1993, 57:1344-1345. 6. Murakami A, Ohura S, Nakamura Y, Koshimizu K, Ohigashi H: 1’- Acetoxychavicol acetate, a superoxide anion generation inhibitor, potently inhibits tumor promotion by 12-O-tetradecanoylphorbol-13- acetate in ICR mouse skin. Oncology 1996, 53(5):386-391. 7. Ichikawa H, Takada Y, Murakami A, Aggarwal BB: Identification of a novel blocker of I kappa B alpha kinase that enhances cellular apoptosis and inhibits cellular invasion through suppression of NF-kappa B-regulated gene products. J Immunol 2005, 174(11):7383-7392. 8. Murakami A, Kuki W, Takahashi Y, Yonei H, Nakamura Y, Ohto Y, Ohigashi H, Koshimizu K: Auraptene, a citrus coumarin, inhibits 12-O- tetradecanoylphorbol-13-acetate-induced tumor promotion in ICR Page 9 of 10 mouse skin, possibly through suppression of superoxide generation in leukocytes. Jpn J Cancer Res 1997, 88(5):443-452. 9. Jun DY, Kim JS, Park HS, Han CR, Fang Z, Woo MH, Rhee IK, Kim YH: Apoptogenic activity of auraptene of Zanthoxylum schinifolium toward human acute leukemia Jurkat T cells is associated with ER stress- mediated caspase-8 activation that stimulates mitochondria-dependent or -independent caspase cascade. Carcinogenesis 2007, 28(6):1303-1313. 10. Yu L, Zhang DM: [Studies on chemical constituents from fruits of Paliurus ramosissimus]. Zhongguo Zhong Yao Za Zhi 2006, 31(24):2049-2052. 11. Murakami A, Ohigashi H: Cancer-preventive anti-oxidants that attenuate free radical generation by inflammatory cells. Biol Chem 2006, 387(4):387-392. 12. Kawabata K, Murakami A, Ohigashi H: Auraptene decreases the activity of matrix metalloproteinases in dextran sulfate sodium-induced ulcerative colitis in ICR mice. Biosci Biotechnol Biochem 2006, 70(12):3062-3065. 13. Kohno H, Suzuki R, Curini M, Epifano F, Maltese F, Gonzales SP, Tanaka T: Dietary administration with prenyloxycoumarins, auraptene and collinin, inhibits colitis-related colon carcinogenesis in mice. Int J Cancer 2006, 118(12):2936-2942. 14. Kuroyanagi K, Kang MS, Goto T, Hirai S, Ohyama K, Kusudo T, Yu R, Yano M, Sasaki T, Takahashi N, et al: Citrus auraptene acts as an agonist for PPARs and enhances adiponectin production and MCP-1 reduction in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2008, 366(1):219-225. 15. Takahashi Y, Inaba N, Kuwahara S, Kuki W, Yamane K, Murakami A: Rapid and convenient method for preparing aurapten-enriched product from hassaku peel oil: implications for cancer-preventive food additives. J Agric Food Chem 2002, 50(11):3193-3196. 16. Clagett-Dame M, DeLuca HF: The role of vitamin A in mammalian reproduction and embryonic development. Annu Rev Nutr 2002, 22:347-381. 17. Maden M, Hind M: Retinoic acid, a regeneration-inducing molecule. Dev Dyn 2003, 226(2):237-244. 18. Love JM, Gudas LJ: Vitamin A, differentiation and cancer. Curr Opin Cell Biol 1994, 6(6):825-831. 19. Chen L-C, De Luca LM: Retinoid effects on skin cancer. Skin Cancer: Mechanisms and human relevance Boca Raton: CRC PressMukhtar H 1994, 401-424. 20. Verma AK: Inhibition of both stage I and stage II mouse skin tumour promotion by retinoic acid and the dependence of inhibition of tumor promotion on the duration of retinoic acid treatment. Cancer Res 1987, 47(19):5097-5101. 21. Cheepala SB, Yin W, Syed Z, Gill JN, McMillian A, Kleiner HE, Lynch M, Loganantharaj R, Trutschl M, Cvek U, et al: Identification of the B-Raf/Mek/ Erk MAP kinase pathway as a target for all-trans retinoic acid during skin cancer promotion. Mol Cancer 2009, 8:27. 22. Syed Z, Cheepala SB, Gill JN, Stein J, Nathan CA, DiGiovanni J, Batra V, Adegboyega P, Kleiner HE, Clifford JL: All-trans retinoic acid suppresses Stat3 signaling during skin carcinogenesis. Cancer Prevention Research 2009, 2:903-911. 23. Carlsen H, Moskaug JO, Fromm SH, Blomhoff R: In vivo imaging of NF- kappa B activity. J Immunol 2002, 168(3):1441-1446. 24. Barwick T, Bencherif B, Mountz JM, Avril N: Molecular PET and PET/CT imaging of tumour cell proliferation using F-18 fluoro-L-thymidine: a comprehensive evaluation. Nucl Med Commun 2009, 30(12):908-917. 25. Martin SJ, Eisenbarth JA, Wagner-Utermann U, Mier W, Henze M, Pritzkow H, Haberkorn U, Eisenhut M: A new precursor for the radiosynthesis of [18F]FLT. Nucl Med Biol 2002, 29(2):263-273. 26. Habig WH, Jakoby WB: Assays for differentiation of glutathione S- transferases. Methods Enzymol 1981, 77:398-405. 27. Kleiner HE, Vulimiri SV, Miller L, Johnson WH, Whitman CP, DiGiovanni J: Oral administration of naturally occurring coumarins leads to altered phase I and II enzyme activities and reduced DNA adduct formation by polycyclic aromatic hydrocarbons in various tissues of SENCAR mice. Carcinogenesis 2001, 22(1):73-82. 28. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254. 29. Habig WH, Pabst MJ, Jakoby WB: Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 1974, 249(22):7130-7139.